Literature DB >> 8746217

A protective role of nitric oxide in isolated ischaemic/reperfused rat heart.

A Beresewicz1, E Karwatowska-Prokopczuk, B Lewartowski, K Cedro-Ceremuåzyńska.   

Abstract

OBJECTIVES: The importance of NO-induced vasodilator tone in maintaining adequate coronary flow to sustain hemodynamic function in aerobically perfused heart and the role of NO in the injury development in ischaemic/reperfused heart was studied.
METHODS: Effect of NO synthesis inhibitor (N omega-nitro-L-arginine, L-NOARG) on isolated working rat hearts subjected to either 90 min of aerobic perfusion or to a global ischaemia (27.5 to 42.5 min) followed by 40 min reperfusion was studied. To overcome coronary flow reducing effect of L-NOARG either perfusion pressure was raised from 75 to 120 cm H2O or adenosine (400 nM) was administered.
RESULTS: In the hearts perfused at coronary pressure of 75 and 120 cm H2O, L-NOARG (10 microM) reduced coronary flow by 30% and 17%, respectively, while cardiac output was not affected. Only a transient increase in adenosine and lactate outflow occurred in L-NOARG-treated hearts. The post-ischaemic recovery of functions was impaired in L-NOARG-treated hearts, an effect not correlating with L-NOARG-induced reduction in coronary flow. Although the pre-ischaemic coronary flow was similar in the untreated hearts perfused at 75 cm H2O and in L-NOARG-treated hearts perfused at 120 cm H2O, the post-ischaemic recovery in the latter group was still impaired as compared to that in the untreated hearts. Likewise, coronary flow was similar in the untreated hearts and in those treated with L-NOARG plus adenosine, nevertheless, the post-ischaemic recovery in the latter group was impaired as compared to that in the untreated hearts.
CONCLUSIONS: While the inhibition of NO synthesis resulted in coronary flow reduction it did not induce a state of permanent ischaemia in isolated rat heart. L-NOARG-induced augmentation of the ischaemia/reperfusion injury was related to the deficit of NO, itself, rather than to the reduction in myocardial perfusion.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8746217     DOI: 10.1016/s0008-6363(95)00175-1

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  6 in total

Review 1.  Peroxynitrite in myocardial ischemia-reperfusion injury.

Authors:  Manoj M Lalu; Wenjie Wang; Richard Schulz
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

Review 2.  Myocardial contractile effects of nitric oxide.

Authors:  Walter J Paulus; Jean G F Bronzwaer
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

3.  Delayed protection against ischaemia-induced ventricular arrhythmias and infarct size limitation by the prior administration of Escherichia coli endotoxin.

Authors:  W Song; B L Furman; J R Parratt
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

4.  Protective effect of picroside II on myocardial ischemia reperfusion injury in rats.

Authors:  Nan Wu; Wenna Li; Wenqi Shu; Dalin Jia
Journal:  Drug Des Devel Ther       Date:  2014-05-14       Impact factor: 4.162

5.  Effect of picroside II on erythrocyte deformability and lipid peroxidation in rats subjected to hind limb ischemia reperfusion injury.

Authors:  Faruk Metin Çomu; Yiğit Kılıç; Abdullah Özer; Mehmet Kirişçi; Ali Doğan Dursun; Tolga Tatar; Mustafa Hakan Zor; Hakan Kartal; Ayşegül Küçük; Hakan Boyunağa; Mustafa Arslan
Journal:  Drug Des Devel Ther       Date:  2016-03-01       Impact factor: 4.162

Review 6.  Interaction of Hydrogen Sulfide with Nitric Oxide in the Cardiovascular System.

Authors:  B V Nagpure; Jin-Song Bian
Journal:  Oxid Med Cell Longev       Date:  2015-11-10       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.